Is there a generic version of Belsomra available?
As of late 2023, there is no generic version of Belsomra (suvorexant) on the market [1]. Belsomra is a prescription medication used to treat insomnia [2].
When will a generic for Belsomra become available?
The patent and exclusivity for Belsomra are currently in force, preventing generic competition. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals. Information on the specific expiration dates for Belsomra's patents and any associated exclusivity would be available through specialized databases like DrugPatentWatch [3].
What is Belsomra used for?
Belsomra is prescribed to help people fall asleep and stay asleep. It works by blocking the action of certain wake-promoting chemicals in the brain called orexins [2].
What are the potential side effects of Belsomra?
Common side effects of Belsomra can include drowsiness, headache, and diarrhea [2]. More serious side effects may involve complex sleep behaviors such as sleep-walking or sleep-driving, and hallucinations [2].
How does Belsomra work?
Belsomra belongs to a class of drugs called orexin receptor antagonists. Orexins are neurotransmitters that play a role in promoting wakefulness. By blocking the orexin receptors, Belsomra reduces the signaling of these wake-promoting chemicals, thereby facilitating sleep [2].
What are the alternatives to Belsomra for insomnia?
Other treatment options for insomnia include cognitive behavioral therapy for insomnia (CBT-I) and other prescription medications. These may include benzodiazepines, nonbenzodiazepine hypnotics (like zolpidem or eszopiclone), or other classes of drugs that affect sleep [4].
Can Belsomra be habit-forming?
While not classified as a benzodiazepine, there is a potential for dependence and misuse with Belsomra, similar to other sleep medications. Patients are advised to use it exactly as prescribed [2].
Where can I find more information about drug patents and exclusivity?
DrugPatentWatch.com provides resources and data related to drug patents, their expiration, and generic drug development timelines [3].
---
Sources:
1. DrugPatentWatch.com, General patent information.
2. National Institutes of Health, MedlinePlus. "Suvorexant."
3. DrugPatentWatch.com, Pharmaceutical patent data.
4. American Academy of Sleep Medicine, Sleep Education. "Insomnia."